IDEXX Laboratories (IDXX) Competitors $427.09 -3.38 (-0.79%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDXX vs. BSX, MDT, BDX, EW, RMD, DXCM, STE, PODD, HOLX, and BAXShould you be buying IDEXX Laboratories stock or one of its competitors? The main competitors of IDEXX Laboratories include Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), and Baxter International (BAX). These companies are all part of the "health care equipment" industry. IDEXX Laboratories vs. Boston Scientific Medtronic Becton, Dickinson and Company Edwards Lifesciences ResMed DexCom STERIS Insulet Hologic Baxter International IDEXX Laboratories (NASDAQ:IDXX) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations. Does the media favor IDXX or BSX? In the previous week, Boston Scientific had 19 more articles in the media than IDEXX Laboratories. MarketBeat recorded 32 mentions for Boston Scientific and 13 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.36 beat Boston Scientific's score of 1.01 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 16 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, IDXX or BSX? Boston Scientific has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEXX Laboratories$3.84B9.10$845.04M$10.3741.19Boston Scientific$15.91B8.38$1.59B$1.2174.74 Do analysts rate IDXX or BSX? IDEXX Laboratories presently has a consensus target price of $539.63, suggesting a potential upside of 26.35%. Boston Scientific has a consensus target price of $95.52, suggesting a potential upside of 5.63%. Given IDEXX Laboratories' higher probable upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Boston Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEXX Laboratories 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.90Boston Scientific 0 Sell rating(s) 3 Hold rating(s) 19 Buy rating(s) 1 Strong Buy rating(s) 2.91 Is IDXX or BSX more profitable? IDEXX Laboratories has a net margin of 22.53% compared to Boston Scientific's net margin of 11.26%. IDEXX Laboratories' return on equity of 55.42% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets IDEXX Laboratories22.53% 55.42% 25.90% Boston Scientific 11.26%17.23%9.52% Do insiders & institutionals have more ownership in IDXX or BSX? 87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 2.1% of IDEXX Laboratories shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, IDXX or BSX? IDEXX Laboratories has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Does the MarketBeat Community believe in IDXX or BSX? Boston Scientific received 508 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. However, 72.36% of users gave IDEXX Laboratories an outperform vote while only 69.65% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformIDEXX LaboratoriesOutperform Votes53472.36% Underperform Votes20427.64% Boston ScientificOutperform Votes104269.65% Underperform Votes45430.35% SummaryIDEXX Laboratories beats Boston Scientific on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get IDEXX Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXX vs. The Competition Export to ExcelMetricIDEXX LaboratoriesDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.97B$2.61B$5.13B$9.29BDividend YieldN/A0.74%4.74%4.06%P/E Ratio41.196.33134.7917.49Price / Sales9.1072.561,255.71139.73Price / Cash37.8115.1640.4137.96Price / Book23.893.344.904.91Net Income$845.04M$29.98M$117.74M$224.90M7 Day Performance-3.96%-4.53%14.56%-1.38%1 Month Performance1.47%11.43%17.54%5.44%1 Year Performance-21.07%-22.43%36.48%22.87% IDEXX Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXXIDEXX Laboratories4.991 of 5 stars$427.09-0.8%$539.63+26.3%-21.1%$34.97B$3.84B41.1911,000Positive NewsBSXBoston Scientific4.5351 of 5 stars$91.14+1.1%$95.52+4.8%+62.0%$134.32B$15.91B75.0248,000Analyst ForecastShort Interest ↑MDTMedtronic4.9709 of 5 stars$82.03-0.5%$95.27+16.1%-1.5%$105.19B$33.00B25.1495,000Options VolumePositive NewsBDXBecton, Dickinson and Company4.9806 of 5 stars$230.54+2.2%$283.50+23.0%-4.8%$66.65B$20.18B37.9774,000Short Interest ↓EWEdwards Lifesciences3.9972 of 5 stars$73.84+0.7%$79.40+7.5%-3.6%$43.55B$6.00B10.7419,800Analyst UpgradeInsider TradeAnalyst RevisionRMDResMed4.6286 of 5 stars$241.02+1.0%$227.91-5.4%+43.5%$35.38B$4.81B31.599,980Analyst RevisionPositive NewsDXCMDexCom4.9889 of 5 stars$76.42-1.0%$98.00+28.2%-36.5%$29.85B$3.95B46.229,600Short Interest ↓STESTERIS4.9508 of 5 stars$213.74-0.2%$262.50+22.8%-1.5%$21.10B$5.14B48.9118,179Positive NewsPODDInsulet4.3598 of 5 stars$266.78-1.0%$267.44+0.2%+27.2%$18.71B$1.70B46.123,000HOLXHologic4.686 of 5 stars$73.14-0.7%$89.50+22.4%+1.8%$16.60B$4.03B22.147,063Analyst RevisionBAXBaxter International4.6335 of 5 stars$29.56-2.5%$40.45+36.9%-23.4%$15.09B$15.06B149.2060,000 Related Companies and Tools Related Companies BSX Alternatives MDT Alternatives BDX Alternatives EW Alternatives RMD Alternatives DXCM Alternatives STE Alternatives PODD Alternatives HOLX Alternatives BAX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IDXX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
